Pfizer Inc (PFE)

Healthcare | Drug Manufacturers General
Income Statement (Quarterly) 2025-03-29 2024-12-31 2024-09-30 2024-09-29
Revenue 13,715,000,000 17,763,000,000 17,702,000,000 17,702,000,000
Cost of Revenue 2,845,000,000 5,909,000,000 5,263,000,000 6,575,000,000
Gross Profit 10,870,000,000 11,854,000,000 12,439,000,000 11,127,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,031,000,000 4,274,000,000 3,244,000,000 3,244,000,000
Operating Expenses 6,445,000,000 8,668,000,000 7,154,000,000 5,842,000,000
Operating Income 4,425,000,000 3,187,000,000 5,285,000,000 5,284,000,000
Interest Expense 654,000,000 739,000,000 783,000,000 783,000,000
Income Before Tax 2,785,000,000 -10,000,000 4,715,000,000 4,715,000,000
Income Tax Expense -189,000,000 -421,000,000 234,000,000 234,000,000
Net Income 2,967,000,000 410,000,000 4,465,000,000 4,465,000,000
Per Share
EPS 0.52 0.07 0.79 0.79
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 63,627,000,000 58,496,000,000 100,330,000,000 81,288,000,000 41,908,000,000
Cost of Revenue 16,420,000,000 29,687,000,000 34,344,000,000 30,821,000,000 8,692,000,000
Gross Profit 47,207,000,000 28,809,000,000 65,986,000,000 50,467,000,000 33,216,000,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 14,730,000,000 14,771,000,000 13,677,000,000 12,703,000,000 11,615,000,000
Operating Expenses 25,552,000,000 25,450,000,000 28,714,000,000 30,232,000,000 24,456,000,000
Operating Income 14,938,000,000 3,359,000,000 40,030,000,000 20,235,000,000 8,760,000,000
Interest Expense 3,091,000,000 2,209,000,000 1,238,000,000 1,291,000,000 1,449,000,000
Income Before Tax 8,023,000,000 1,058,000,000 34,729,000,000 24,311,000,000 7,497,000,000
Income Tax Expense -28,000,000 -1,114,000,000 3,328,000,000 1,852,000,000 477,000,000
Net Income 8,031,000,000 2,119,000,000 31,372,000,000 21,979,000,000 9,616,000,000
Per Share
EPS 1.42 0.38 5.59 3.92 1.73
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 1,043,000,000 2,853,000,000 416,000,000 1,944,000,000
Short Term Investments 19,434,000,000 9,837,000,000 22,316,000,000 29,125,000,000
Net Receivables 14,777,000,000 11,177,000,000 14,529,000,000 15,745,000,000
Inventory 10,851,000,000 10,189,000,000 8,981,000,000 9,059,000,000
Total Current Assets 50,358,000,000 43,333,000,000 51,259,000,000 59,693,000,000
Property Plant Equipment 18,393,000,000 21,864,000,000 16,274,000,000 14,882,000,000
Goodwill and Intangibles 123,939,000,000 132,683,000,000 94,745,000,000 74,354,000,000
Total Assets 213,396,000,000 226,501,000,000 197,206,000,000 181,476,000,000
Liabilities
Account Payables 5,633,000,000 6,710,000,000 6,809,000,000 5,578,000,000
Short Term Debt 6,946,000,000 7,574,000,000 2,945,000,000 2,241,000,000
Total Current Liabilities 42,995,000,000 47,794,000,000 42,138,000,000 42,671,000,000
Long Term Debt 56,703,000,000 64,164,000,000 31,925,000,000 34,757,000,000
Total Liabilities 124,899,000,000 137,213,000,000 101,289,000,000 104,014,000,000
Shareholders Equity
Retained Earnings 116,725,000,000 118,353,000,000 125,656,000,000 103,394,000,000
Total Shareholders Equity 88,203,000,000 89,014,000,000 95,661,000,000 77,201,000,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 1,043,000,000 2,853,000,000 416,000,000 1,944,000,000 1,784,000,000
Short Term Investments 19,434,000,000 9,837,000,000 22,316,000,000 29,125,000,000 10,437,000,000
Net Receivables 14,777,000,000 11,177,000,000 14,529,000,000 15,745,000,000 11,194,000,000
Inventory 10,851,000,000 10,189,000,000 8,981,000,000 9,059,000,000 8,046,000,000
Total Current Assets 50,358,000,000 43,333,000,000 51,259,000,000 59,693,000,000 35,067,000,000
Property Plant Equipment 18,393,000,000 21,864,000,000 16,274,000,000 14,882,000,000 13,900,000,000
Goodwill and Intangibles 123,939,000,000 132,683,000,000 94,745,000,000 74,354,000,000 78,049,000,000
Total Assets 213,396,000,000 226,501,000,000 197,206,000,000 181,476,000,000 154,230,000,000
Liabilities
Account Payables 5,633,000,000 6,710,000,000 6,809,000,000 5,578,000,000 4,309,000,000
Short Term Debt 6,946,000,000 7,574,000,000 2,945,000,000 2,241,000,000 2,703,000,000
Total Current Liabilities 42,995,000,000 47,794,000,000 42,138,000,000 42,671,000,000 25,920,000,000
Long Term Debt 56,703,000,000 64,164,000,000 31,925,000,000 34,757,000,000 35,571,000,000
Total Liabilities 124,899,000,000 137,213,000,000 101,289,000,000 104,014,000,000 90,756,000,000
Shareholders Equity
Retained Earnings 116,725,000,000 118,353,000,000 125,656,000,000 103,394,000,000 96,770,000,000
Total Shareholders Equity 88,203,000,000 89,014,000,000 95,661,000,000 77,201,000,000 63,238,000,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income 8,051,000,000 2,133,000,000 31,401,000,000 21,979,000,000
Depreciation & Amortization 7,013,000,000 6,290,000,000 5,064,000,000 5,191,000,000
Stock Based Compensation 877,000,000 545,000,000 872,000,000 1,182,000,000
Change in Working Capital -3,066,000,000 -2,172,000,000 -4,456,000,000 12,804,000,000
Operating Cash Flow 12,744,000,000 8,700,000,000 29,267,000,000 32,580,000,000
Investing Activities
Capital Expenditure -2,909,000,000 -3,907,000,000 -3,236,000,000 -2,711,000,000
Investments -2,909,000,000 -3,907,000,000 -3,236,000,000 -2,711,000,000
Investing Cash Flow 2,652,000,000 -32,278,000,000 -15,783,000,000 -22,546,000,000
Financing Activities
Debt Repayment -7,159,000,000 -35,945,000,000 -7,407,000,000 -2,100,000,000
Common Stock Issued/Repurchased 0 0 -2,000,000,000 0
Dividends Paid -9,512,000,000 -9,247,000,000 -8,983,000,000 -8,729,000,000
Financing Cash Flow -17,140,000,000 26,066,000,000 -14,834,000,000 -9,816,000,000
Summary
Free Cash Flow 9,835,000,000 4,793,000,000 26,031,000,000 29,869,000,000
Net Change in Cash -1,810,000,000 2,437,000,000 -1,515,000,000 158,000,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income 8,051,000,000 2,133,000,000 31,401,000,000 21,979,000,000 9,616,000,000
Depreciation & Amortization 7,013,000,000 6,290,000,000 5,064,000,000 5,191,000,000 4,777,000,000
Stock Based Compensation 877,000,000 545,000,000 872,000,000 1,182,000,000 756,000,000
Change in Working Capital -3,066,000,000 -2,172,000,000 -4,456,000,000 12,804,000,000 -275,000,000
Operating Cash Flow 12,744,000,000 8,700,000,000 29,267,000,000 32,580,000,000 14,403,000,000
Investing Activities
Capital Expenditure -2,909,000,000 -3,907,000,000 -3,236,000,000 -2,711,000,000 -2,791,000,000
Investments -2,909,000,000 -3,907,000,000 -3,236,000,000 -2,711,000,000 -2,252,000,000
Investing Cash Flow 2,652,000,000 -32,278,000,000 -15,783,000,000 -22,546,000,000 -4,271,000,000
Financing Activities
Debt Repayment -7,159,000,000 -35,945,000,000 -7,407,000,000 -2,100,000,000 -30,329,000,000
Common Stock Issued/Repurchased 0 0 -2,000,000,000 0 0
Dividends Paid -9,512,000,000 -9,247,000,000 -8,983,000,000 -8,729,000,000 -8,440,000,000
Financing Cash Flow -17,140,000,000 26,066,000,000 -14,834,000,000 -9,816,000,000 -9,649,000,000
Summary
Free Cash Flow 9,835,000,000 4,793,000,000 26,031,000,000 29,869,000,000 11,612,000,000
Net Change in Cash -1,810,000,000 2,437,000,000 -1,515,000,000 158,000,000 475,000,000